{"log_id": 5860915302240075416, "direction": 0, "words_result_num": 49, "words_result": [{"probability": {"variance": 1.6e-05, "average": 0.998632, "min": 0.976344}, "location": {"width": 873, "top": 120, "height": 45, "left": 196}, "words": "现有的信息尚不足以排除本品对胎儿和新生儿的不良影响。因此怀孕20周以上的妇女在使用本"}, {"probability": {"variance": 2e-06, "average": 0.998796, "min": 0.993654}, "location": {"width": 681, "top": 154, "height": 41, "left": 176}, "words": "品时应仔细权衡利弊,仅在其它治疗方法不适用或无效时才考虑应用本品"}, {"probability": {"variance": 6e-06, "average": 0.998901, "min": 0.985268}, "location": {"width": 851, "top": 178, "height": 44, "left": 218}, "words": "妊娠妇女给予硝苯地平并同时静注硫酸镁时,由于血压可能过低而影响母亲和胎儿,故应密"}, {"probability": {"variance": 1e-06, "average": 0.998955, "min": 0.996939}, "location": {"width": 107, "top": 224, "height": 26, "left": 177}, "words": "切监测血压"}, {"probability": {"variance": 5.8e-05, "average": 0.997774, "min": 0.952938}, "location": {"width": 851, "top": 236, "height": 44, "left": 220}, "words": "个别体外受精的案例中,硝苯地平类钙离子拮抗剂与精子头部的可逆性生化改变有关,从而"}, {"probability": {"variance": 2e-06, "average": 0.999114, "min": 0.993354}, "location": {"width": 895, "top": 264, "height": 47, "left": 177}, "words": "损伤精子的功能。那些反复进行体外试管受精不成功的男性,在无其它原因可寻时,应考虑到硝"}, {"probability": {"variance": 6e-06, "average": 0.999228, "min": 0.990113}, "location": {"width": 345, "top": 305, "height": 34, "left": 178}, "words": "苯地平类钙离子拮抗剂可能是其原因"}, {"probability": {"variance": 0, "average": 0.999743, "min": 0.999286}, "location": {"width": 110, "top": 338, "height": 27, "left": 220}, "words": "哺乳期妇女"}, {"probability": {"variance": 3.8e-05, "average": 0.997795, "min": 0.960135}, "location": {"width": 995, "top": 339, "height": 63, "left": 218}, "words": "硝苯地平能进入母乳。因为尚无对婴儿可能产生何种影响的报告,所以哺乳期间必须服用硝国家食品"}, {"probability": {"variance": 0, "average": 0.999404, "min": 0.997618}, "location": {"width": 255, "top": 394, "height": 32, "left": 179}, "words": "苯地平时,首先要停止哺乳"}, {"probability": {"variance": 0.086642, "average": 0.789327, "min": 0.373062}, "location": {"width": 83, "top": 386, "height": 30, "left": 1123}, "words": "药品"}, {"probability": {"variance": 0.000689, "average": 0.987197, "min": 0.928512}, "location": {"width": 120, "top": 443, "height": 25, "left": 160}, "words": "【儿童用药】"}, {"probability": {"variance": 0, "average": 0.999164, "min": 0.999112}, "location": {"width": 71, "top": 428, "height": 30, "left": 1134}, "words": "附件"}, {"probability": {"variance": 1.5e-05, "average": 0.99838, "min": 0.983631}, "location": {"width": 345, "top": 465, "height": 35, "left": 199}, "words": "尚无儿童用药的安全性和有效性资料"}, {"probability": {"variance": 2e-06, "average": 0.998689, "min": 0.995988}, "location": {"width": 118, "top": 516, "height": 26, "left": 162}, "words": "【老年用药】"}, {"probability": {"variance": 5e-06, "average": 0.998048, "min": 0.993462}, "location": {"width": 283, "top": 555, "height": 34, "left": 198}, "words": "尚无本品用于老年患者的资料"}, {"probability": {"variance": 8e-06, "average": 0.996851, "min": 0.991198}, "location": {"width": 156, "top": 605, "height": 27, "left": 163}, "words": "【药物相互作用】"}, {"probability": {"variance": 1e-06, "average": 0.999047, "min": 0.996868}, "location": {"width": 194, "top": 631, "height": 27, "left": 212}, "words": "影响硝苯地平的药物"}, {"probability": {"variance": 0.000984, "average": 0.988425, "min": 0.856651}, "location": {"width": 870, "top": 647, "height": 43, "left": 211}, "words": "硝苯地平通过位于肠粘膜和肝脏的细胞色素P4503A4系统代谢消除。因此对细胞色素P4503A4"}, {"probability": {"variance": 2e-06, "average": 0.999094, "min": 0.993026}, "location": {"width": 748, "top": 678, "height": 42, "left": 183}, "words": "系统有抑制或诱导作用的药物可能改变硝苯地平的首过效应(口服后)或清除率"}, {"probability": {"variance": 3e-06, "average": 0.998871, "min": 0.991633}, "location": {"width": 578, "top": 710, "height": 38, "left": 213}, "words": "硝苯地平与下列药物合用时应考虑相互作用的程度和持续时间"}, {"probability": {"variance": 0, "average": 0.99901, "min": 0.998336}, "location": {"width": 66, "top": 749, "height": 25, "left": 214}, "words": "利福平"}, {"probability": {"variance": 5.4e-05, "average": 0.996564, "min": 0.96581}, "location": {"width": 868, "top": 762, "height": 43, "left": 213}, "words": "具有很强的诱导细胞色素P4503A4系统的作用如与之合用,硝苯地平的生物利用度会降低"}, {"probability": {"variance": 3.4e-05, "average": 0.997743, "min": 0.978588}, "location": {"width": 451, "top": 797, "height": 38, "left": 186}, "words": "而影响其疗效。因此硝苯地平禁止与利福平合用"}, {"probability": {"variance": 3.1e-05, "average": 0.997829, "min": 0.969369}, "location": {"width": 869, "top": 819, "height": 43, "left": 215}, "words": "硝苯地平与下列细胞色素P4503A4系统的弱效至中效抑制剂合用时应监测血压,如有必要应"}, {"probability": {"variance": 3e-06, "average": 0.998666, "min": 0.99361}, "location": {"width": 282, "top": 859, "height": 31, "left": 185}, "words": "考虑减少硝苯地平的服用剂量"}, {"probability": {"variance": 2.1e-05, "average": 0.9977, "min": 0.980969}, "location": {"width": 316, "top": 885, "height": 33, "left": 216}, "words": "大环内酯类抗生素(例如红霉素)"}, {"probability": {"variance": 5e-06, "average": 0.998944, "min": 0.988012}, "location": {"width": 868, "top": 903, "height": 45, "left": 217}, "words": "目前尚未开展硝苯地平与大环内酯类抗生素相互作用的研究,已知某些大环内酯类抗生素可抑"}, {"probability": {"variance": 2.8e-05, "average": 0.997038, "min": 0.976706}, "location": {"width": 899, "top": 933, "height": 44, "left": 186}, "words": "制细胞色素P4503A4介导的其它药物的代谢。因此尚不能排除与硝苯地平合用后可增加硝苯地平"}, {"probability": {"variance": 0, "average": 0.999518, "min": 0.998518}, "location": {"width": 197, "top": 974, "height": 27, "left": 186}, "words": "血药浓度的潜在作用"}, {"probability": {"variance": 6e-06, "average": 0.998598, "min": 0.988985}, "location": {"width": 805, "top": 991, "height": 42, "left": 214}, "words": "阿奇霉素虽在结构上属于大环内酯类抗生素,但对细胞色素P4503A4系统无抑制作用"}, {"probability": {"variance": 0.002048, "average": 0.979776, "min": 0.828564}, "location": {"width": 359, "top": 1030, "height": 30, "left": 218}, "words": "抗-HIV蛋白酶抑制剂(例如利托那韦"}, {"probability": {"variance": 0.001308, "average": 0.992736, "min": 0.763238}, "location": {"width": 869, "top": 1049, "height": 40, "left": 218}, "words": "目前还未进行硝苯地平与抗-HIV蛋白酶抑制剂之间可能存在的药物相互作用的临床研究。已"}, {"probability": {"variance": 0.000147, "average": 0.99373, "min": 0.941284}, "location": {"width": 897, "top": 1076, "height": 42, "left": 188}, "words": "知这类药物可抑制细胞色素P4503A4系统。另外,此类药物在体外可抑制细胞色素P4503A4介"}, {"probability": {"variance": 1e-06, "average": 0.999322, "min": 0.996005}, "location": {"width": 899, "top": 1104, "height": 42, "left": 188}, "words": "导的硝苯地平的代谢。因此尚不能排除此类药物与硝苯地平同时使用时,由于首过效应降低和排"}, {"probability": {"variance": 2e-06, "average": 0.999181, "min": 0.994493}, "location": {"width": 454, "top": 1141, "height": 34, "left": 188}, "words": "除量减少引起的硝苯地平血药浓度升高的可能性"}, {"probability": {"variance": 0.000548, "average": 0.990549, "min": 0.907046}, "location": {"width": 292, "top": 1189, "height": 26, "left": 215}, "words": "吡咯类抗真菌药(例如酮康唑)"}, {"probability": {"variance": 0.000108, "average": 0.989574, "min": 0.9792}, "location": {"width": 79, "top": 1166, "height": 41, "left": 887}, "words": "林制"}, {"probability": {"variance": 0.004017, "average": 0.986632, "min": 0.590831}, "location": {"width": 869, "top": 1205, "height": 44, "left": 221}, "words": "目前还未进行硝苯地平与吡咯类抗真菌药相互作用的临床研究。巴知此类药物可抑制细胞色素"}, {"probability": {"variance": 0.00042, "average": 0.99322, "min": 0.867315}, "location": {"width": 905, "top": 1231, "height": 47, "left": 187}, "words": "P4503A4系统。因此与硝苯地平同时口服时,尚不能排除因为首过效应降低而使硝苯地平生物利"}, {"probability": {"variance": 6e-06, "average": 0.998025, "min": 0.993051}, "location": {"width": 173, "top": 1277, "height": 27, "left": 191}, "words": "用度增加的可能性"}, {"probability": {"variance": 1e-06, "average": 0.999059, "min": 0.99811}, "location": {"width": 66, "top": 1322, "height": 26, "left": 217}, "words": "氟西汀"}, {"probability": {"variance": 0.010036, "average": 0.973222, "min": 0.470899}, "location": {"width": 875, "top": 1352, "height": 44, "left": 218}, "words": "目前还未进行硝苯地平与氟西汀之间可能存在的药物相互作用的临床研究。氟西汀在体外可抑"}, {"probability": {"variance": 6e-05, "average": 0.997174, "min": 0.963622}, "location": {"width": 925, "top": 1382, "height": 42, "left": 167}, "words": "制细胞色素P4503A4介导的硝苯地平的代谢。因此尚不能排除这两种药物同时使用时硝苯地平血药"}, {"probability": {"variance": 0, "average": 0.999485, "min": 0.998509}, "location": {"width": 175, "top": 1422, "height": 28, "left": 167}, "words": "浓度升高的可能性"}, {"probability": {"variance": 0.000213, "average": 0.982074, "min": 0.967152}, "location": {"width": 88, "top": 1467, "height": 26, "left": 218}, "words": "奈法唑酮"}, {"probability": {"variance": 0.000494, "average": 0.99494, "min": 0.856031}, "location": {"width": 872, "top": 1499, "height": 39, "left": 220}, "words": "目前还未进行硝苯地平与奈法唑酮之间可能存在的药物相互作用的临床研究。已知奈法唑酮可"}, {"probability": {"variance": 0.000554, "average": 0.993638, "min": 0.843649}, "location": {"width": 922, "top": 1527, "height": 40, "left": 169}, "words": "抑制细胞色素P4503A4介导的其它药物的代谢。因此尚不能排除这两种药物同时使用时硝苯地平血"}, {"probability": {"variance": 7e-06, "average": 0.997839, "min": 0.99162}, "location": {"width": 194, "top": 1565, "height": 29, "left": 169}, "words": "药浓度升高的可能性"}], "language": 3}